Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)

Introduction: Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in patients with severe infections, malignancy or autoimmune diseases. It is also a rare complication of haematopoetic stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandler, Robert David, Tattersall, Rachel Scarlett, Schoemans, Helene, Greco, Raffaella, Badoglio, Manuela, Labopin, Myriam, Alexander, Tobias, Kirgizov, Kirill, Rovira, Montserrat, Saif, Muhammad, Saccardi, Riccardo, Delgado, Julio, Peric, Zinaida, Koenecke, Christian, Penack, Olaf, Basak, Grzegorz, Snowden, John Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137396/
https://www.ncbi.nlm.nih.gov/pubmed/32296434
http://dx.doi.org/10.3389/fimmu.2020.00524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137396/
https://www.ncbi.nlm.nih.gov/pubmed/32296434
http://dx.doi.org/10.3389/fimmu.2020.00524

Ejemplares similares